Brexpiprazole Treatment for Bipolar I Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Brexpiprazole Treatment for Bipolar I Depression — Stella

Recruiting

Back to Bipolar Depression trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

Canada

McMaster University, Hamilton, Ontario

Jewish General Hospital, Montreal, Quebec

Douglas Mental Health University Institute, Montreal, Quebec

Key details

Phase

Large-scale testing

Sponsor

Douglas Mental Health University Institute

Collaborators

McMaster University, Jewish General Hospital

Enrollment target

~58 participants

Started

May 2021

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov